Company Aeolus Pharmaceuticals, Inc. Other OTC
Equities
AOLS
US00765G1094
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -33.27% |
Sales per region
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -33.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 31/05/05 |
David Cavalier
CHM | Chairman | 54 | 29/04/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 29/04/04 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 07/05/13 |
John Clerici
BRD | Director/Board Member | 54 | 07/05/13 |
Amit Kumar
BRD | Director/Board Member | 59 | 31/05/04 |
Chris Rallis
BRD | Director/Board Member | 70 | 31/05/04 |
John Farah
BRD | Director/Board Member | 72 | 20/10/05 |
Mitchell Kaye
BRD | Director/Board Member | 56 | 07/05/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 152,085,825 | 152,085,825 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 4,500 | 0 | 0 |
Company contact information
Aeolus Pharmaceuticals, Inc.
26361 Crown Valley Parkway Suite 150
92691-7324, Mission Viejo
+949-481-9825
Sector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |